Reset filter
Mots-clés
Afficher plus Mots-clés
Table des matières
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
    1. 7.1. Anesthésie
    1. 7.2. Dermatologie
    1. 7.3. HNO
    1. 7.4. Gériatrie
    1. 7.5. Gynécologie/obstétrique
    1. 7.6. Médecine interne
      1. Hématologie
      1. Infectiologie
      1. Cardiologie/angiologie
      1. Pneumologie
      1. Gastroentérologie
      1. Néphrologie
      1. Endocrinologie/métabolisme
      1. Rhumatologie
    1. 7.7. Neurologie
    1. 7.8. Ophtalmologie
    1. 7.9. Médecine palliative
    1. 7.10. Pathologie/médécine légale
    1. 7.11. Pédiatrie
    1. 7.12. Psychiatrie/psychosomatique
    1. 7.13. Radiologie
    1. 7.14. Chirurgie
      1. Chirurgie générale/viscérale
      1. Neurochirurgie
      1. Chirurgie plastique
      1. Chirurgie cardiaque/thoracique
      1. Chirurgie traumatologique/orthopédie
      1. Chirurgie vasculaire
    1. 7.15. Urologie
    1. 7.16. Médecine dentaire/MKG
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

2252 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Eligibility Metabolic Syndrome NCT00917449

- 03/05/2017 - 1 Formulaire, 2 Groupes Item, 17 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00917449

Eligibility Metabolic Syndrome NCT02517697

- 08/05/2019 - 1 Formulaire, 2 Groupes Item, 16 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Oral Nitrite Placebo Controlled Trial for Hypertension and Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT02517697

Eligibility Metabolic Syndrome NCT01705678

- 06/01/2019 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01705678

Eligibility Metabolic Syndrome NCT00937638

- 16/06/2018 - 1 Formulaire, 2 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00937638

Eligibility Metabolic Syndrome NCT00655902

- 15/06/2018 - 1 Formulaire, 2 Groupes Item, 16 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Copenhagen Obesity Risk Assessment Study; ODM derived from: https://clinicaltrials.gov/show/NCT00655902

Eligibility Metabolic Syndrome NCT00170937

- 19/10/2016 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00170937

Eligibility Metabolic Syndrome X NCT00269646

- 20/10/2016 - 1 Formulaire, 2 Groupes Item, 9 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Comparison of Two Different Diets on Health Outcomes; ODM derived from: https://clinicaltrials.gov/show/NCT00269646

Eligibility Diabetes NCT01630980

- 20/12/2018 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT01630980

Eligibility Diabetes NCT01473329

- 12/11/2019 - 1 Formulaire, 2 Groupes Item, 13 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Structured Diabetes Self-Management Education in Primary Care and Metabolic Control; ODM derived from: https://clinicaltrials.gov/show/NCT01473329

Eligibility Hypertension With Metabolic Syndrome NCT00542269

- 05/05/2018 - 1 Formulaire, 2 Groupes Item, 18 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00542269

Eligibility Diabetes Mellitus NCT02310555

- 27/09/2021 - 1 Formulaire, 2 Groupes Item, 14 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Surgical Techniques in Diabetes Mellitus-II and Obesity. Metabolic Surgery Study (MSS); ODM derived from: https://clinicaltrials.gov/show/NCT02310555

Extension balance and metabolic disposition of vilanterol as a single oral dose. 106181 - Follow-Up

- 14/12/2018 - 1 Formulaire, 7 Groupes Item, 41 Eléments de données, 1 Langue
Groupes Item: Physical Examination, Vital Signs, 12 lead ECG, 12 lead ECG, Abnormality, Laboratory Procedures, Chemistry, Clinical, Laboratory Procedures, Hematology finding, Laboratory Procedures, Urinalysis
Study ID: 106181 Clinical Study ID: B2C106181 Study Title: An open-label, single-arm study to determine the excretion balance and metabolic disposition of [14C]GW642444 administered as a single dose of an oral solution to healthy male volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01286831 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: vilanterol Trade Name: Study Indication: Pulmonary Disease, Chronic Obstructive

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial